2/28
04:52 pm
vir
Rating for VIR
Medium
Report
Rating for VIR
2/28
04:52 pm
vir
Rating for VIR
Medium
Report
Rating for VIR
2/28
09:48 am
vir
Vir Biotechnology, Inc. (NASDAQ: VIR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $110.00 price target on the stock.
Medium
Report
Vir Biotechnology, Inc. (NASDAQ: VIR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $110.00 price target on the stock.
2/27
08:08 am
vir
Vir Biotechnology, Inc. (NASDAQ: VIR) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $19.00 price target on the stock.
Medium
Report
Vir Biotechnology, Inc. (NASDAQ: VIR) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $19.00 price target on the stock.
2/27
08:00 am
vir
Rating for VIR
High
Report
Rating for VIR
2/27
08:00 am
vir
Rating for VIR
High
Report
Rating for VIR
1/31
08:09 am
vir
Vir Biotechnology, Inc. (NASDAQ: VIR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $110.00 price target on the stock.
Low
Report
Vir Biotechnology, Inc. (NASDAQ: VIR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $110.00 price target on the stock.
1/13
11:17 am
vir
Rating for VIR
Low
Report
Rating for VIR
1/10
08:04 am
vir
Vir Biotechnology, Inc. (NASDAQ: VIR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $110.00 price target on the stock.
Low
Report
Vir Biotechnology, Inc. (NASDAQ: VIR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $110.00 price target on the stock.
1/9
08:25 am
vir
Vir Biotechnology, Inc. (NASDAQ: VIR) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $20.00 price target on the stock, up previously from $10.00.
Medium
Report
Vir Biotechnology, Inc. (NASDAQ: VIR) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $20.00 price target on the stock, up previously from $10.00.
1/9
08:25 am
vir
Vir Biotechnology, Inc. (NASDAQ: VIR) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $20.00 price target on the stock, up previously from $10.00.
Medium
Report
Vir Biotechnology, Inc. (NASDAQ: VIR) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $20.00 price target on the stock, up previously from $10.00.
1/9
08:12 am
vir
Rating for VIR
Report
Rating for VIR
1/9
08:12 am
vir
Rating for VIR
Report
Rating for VIR
1/9
06:28 am
vir
Rating for VIR
Report
Rating for VIR
1/9
05:14 am
vir
Vir Biotechnology upgraded to Overweight from Equal Weight at Morgan Stanley
Medium
Report
Vir Biotechnology upgraded to Overweight from Equal Weight at Morgan Stanley
1/9
05:14 am
vir
Vir Biotechnology upgraded to Overweight from Equal Weight at Morgan Stanley
Medium
Report
Vir Biotechnology upgraded to Overweight from Equal Weight at Morgan Stanley